← Evidence map

ArticleNature cancer2023

Ricolinostat is not a highly selective HDAC6 inhibitor.

Guillaume Médard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37322365